USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ANCORA PHARMACEUTICALS, INC.
City: MEDFORD
State: MA
Zip+4: 99999-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,093,975.00 4
SBIR Phase II $3,320,986.00 1

Award List:

Synthesis and Optimization of a Malaria Vaccine

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Obadih J. Plante
Award Amount: $130,750.00
Abstract:
DESCRIPTION (provided by applicant): Plasmodium falciparum malaria infects 5-10% of the global population (400 million clinical cases) and kills two million people annually. As such it ranks along with HIV and TB as the most serious infectious disease of humanity. It is widely accepted that an… More

Synthesis & Characterization of a Tuberculosis Vaccine

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Obadih J. Plante
Award Amount: $133,000.00
Abstract:
DESCRIPTION (provided by applicant): Tuberculosis (TB) has plagued mankind for millennia. While several drugs and vaccine strategies have been developed to counter the TB, it remains a major infectious cause of morbidity and mortality worldwide. 1.Though the elucidation of the M. tuberculosis… More

Development of an anti-malaria toxin vaccine candidate

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: William J. Christ
Award Amount: $3,320,986.00
Abstract:
DESCRIPTION (provided by applicant): Malarial disease represents one of the most pressing medical healthcare issues facing the world today. While limited drug treatment options exist, a vaccine solution is widely considered as one of the most effective therapeutic weapons to combat malaria. Despite… More

Evaluation of a synthetic anti-GPI vaccine candidate in severe anemia models of m

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: A. S. Campbell
Award Amount: $530,977.00
Abstract:
DESCRIPTION (provided by applicant): Plasmodium falciparum malaria afflicts up to 10% of the global population, resulting in over 600 million infections and two to three million deaths annually. Malaria-related fatalities arise predominantly from two clini cally defined complications associated with… More

SYNTHESIS OF GLYCOSAMINOGLYCANS

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Obadiah Plante – 781-395-7700
Award Amount: $299,248.00
Abstract:
The glycosaminoglycan (GAG) class of carbohydrates is characterized by unparalleled sequence diversity. Located on the cell surface and in the extracellular matrix, specific structural features are required for a variety of functions including coagulation, cell-signaling and wound healing among… More